SciELO - Scientific Electronic Library Online

vol.29 issue2Clinical Aspects of Fatty Liver Disease at a Tertiary Medical Center in Bogotá from 2009 to 2013Update on Approaches to Patients with Dyspepsia and Functional Dyspepsia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista Colombiana de Gastroenterologia

Print version ISSN 0120-9957


OSORIO, álvaro; OTERO REGINO, William  and  GOMEZ ZULETA, Martín. The Use of NSAIDs Combined with Prophylactic Use of PPIs for Internal Medicine Patients. Rev Col Gastroenterol [online]. 2014, vol.29, n.2, pp.125-130. ISSN 0120-9957.

Introduction: Adverse gastrointestinal events related to non-steroid anti-inflammatory drugs (NSAIDs) which are frequently prescribed in medical practice increase morbidity and mortality. These can be reduced through prophylactic use of proton pump inhibitors proton pump (PPIs) or misoprostol anti H2. Objective: The objective of this study was to estimate the prevalence of NSAIDs use in a population of internal medicine outpatients and to determine the frequency of prophylactic prescriptions of PPIs for patients at risk of gastrointestinal bleeding. Methods: This was a prospective and analytical study of prevalence among patients over 18 years of age in the Internal Medicine outpatient service at the Hospital San Carlos in Bogota. Patients who consume NSAIDs were classified into three risk groups based on traditionally described risk factors for gastrointestinal bleeding. Results: Thirty percent of the 140 enrolled patients were taking NSAIDs. 47.6 % (n = 20) were classified in the low risk group, 28.5 % (n = 12) in the intermediate-risk group and 23.8 % (n = 10) in the high risk group. 47% (20 patients) of those taking NSAIDs were simultaneously taking PPIs. Eighty percent of the high risk group, 50% of the intermediate-risk group, and 30% of the low risk group were taking PPIs. Conclusion: PPIs were prescribed more frequently for high risk patients in this study population (80%) than has been that reported in international publications (less than 50%). The prescription of PPIs for 30% of the low risk patients is unnecessary.

Keywords : NSAIDs; PPIs; prophylaxis; gastrointestinal protection.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )